Overview
David Greaves practices in Oxford, United Kingdom. Mr. Greaves is rated as an Advanced expert by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. His top areas of expertise are GTP Cyclohydrolase 1 Deficiency, Secondary Peritonitis, Peritonitis, and Atherosclerosis.
His clinical research consists of co-authoring 86 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of GTP Cyclohydrolase 1 Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AtherosclerosisMr. Greaves isAdvanced. Learn about Atherosclerosis.
- Cerebral HypoxiaMr. Greaves isAdvanced. Learn about Cerebral Hypoxia.
- GTP Cyclohydrolase 1 DeficiencyMr. Greaves isAdvanced. Learn about GTP Cyclohydrolase 1 Deficiency.
- PeritonitisMr. Greaves isAdvanced. Learn about Peritonitis.
- Secondary PeritonitisMr. Greaves isAdvanced. Learn about Secondary Peritonitis.
- Experienced
- Hairy Cell Leukemia (HCL)Mr. Greaves isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Heart AttackMr. Greaves isExperienced. Learn about Heart Attack.
- SepsisMr. Greaves isExperienced. Learn about Sepsis.
- Thoracic Aortic AneurysmMr. Greaves isExperienced. Learn about Thoracic Aortic Aneurysm.
- X-Linked Severe Combined ImmunodeficiencyMr. Greaves isExperienced. Learn about X-Linked Severe Combined Immunodeficiency.